Biomind Labs Inc.
BMNDF
$0.12
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 844.40K | 356.30K | 370.20K | 384.00K | 379.40K |
| Depreciation & Amortization | 2.20K | 4.40K | 6.60K | 8.80K | 8.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 846.60K | 389.10K | 393.00K | 409.00K | 404.50K |
| Operating Income | -846.60K | -389.10K | -393.00K | -409.00K | -404.50K |
| Income Before Tax | -850.40K | -113.80K | -45.50K | -141.10K | -260.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.85 | -0.11 | -0.05 | -0.14 | -0.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -850.40K | -113.80K | -45.50K | -141.10K | -260.50K |
| EBIT | -846.60K | -389.10K | -393.00K | -409.00K | -404.50K |
| EBITDA | -844.40K | -384.70K | -386.30K | -400.10K | -395.50K |
| EPS Basic | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 310.29M | 310.29M | 307.19M | 304.38M | 301.57M |
| Average Diluted Shares Outstanding | 310.29M | 310.29M | 307.19M | 304.38M | 301.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |